Report Detail
Global Sickle Cell Disease Treatment Market Insights, Forecast to 2025
- RnM3525734 |
- 14 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.
The global Sickle Cell Disease Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sickle Cell Disease Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Sickle Cell Disease Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sickle Cell Disease Treatment in these regions.
This research report categorizes the global Sickle Cell Disease Treatment market by top players/brands, region, type and end user. This report also studies the global Sickle Cell Disease Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Eli Lilly
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird bio
Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Market size by Product
Sickle Cell Anemia
Sickle Beta Thalassemia
Sickle Hemoglobin C Disease
Market size by End User
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Sickle Cell Disease Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sickle Cell Disease Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sickle Cell Disease Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sickle Cell Disease Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sickle Cell Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sickle Cell Disease Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Sickle Cell Disease Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Product
- 1.4.2 Sickle Cell Anemia
- 1.4.3 Sickle Beta Thalassemia
- 1.4.4 Sickle Hemoglobin C Disease
- 1.5 Market by End User
- 1.5.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sickle Cell Disease Treatment Market Size
- 2.1.1 Global Sickle Cell Disease Treatment Revenue 2014-2025
- 2.1.2 Global Sickle Cell Disease Treatment Sales 2014-2025
- 2.2 Sickle Cell Disease Treatment Growth Rate by Regions
- 2.2.1 Global Sickle Cell Disease Treatment Sales by Regions
- 2.2.2 Global Sickle Cell Disease Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Sickle Cell Disease Treatment Sales by Manufacturers
- 3.1.1 Sickle Cell Disease Treatment Sales by Manufacturers
- 3.1.2 Sickle Cell Disease Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Sickle Cell Disease Treatment Revenue by Manufacturers
- 3.2.1 Sickle Cell Disease Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Sickle Cell Disease Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Sickle Cell Disease Treatment Price by Manufacturers
- 3.4 Sickle Cell Disease Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Sickle Cell Disease Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Sickle Cell Disease Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Sickle Cell Disease Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Sickle Cell Disease Treatment Sales by Product
- 4.2 Global Sickle Cell Disease Treatment Revenue by Product
- 4.3 Sickle Cell Disease Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Sickle Cell Disease Treatment Breakdown Data by End User
6 North America
- 6.1 North America Sickle Cell Disease Treatment by Countries
- 6.1.1 North America Sickle Cell Disease Treatment Sales by Countries
- 6.1.2 North America Sickle Cell Disease Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Sickle Cell Disease Treatment by Product
- 6.3 North America Sickle Cell Disease Treatment by End User
7 Europe
- 7.1 Europe Sickle Cell Disease Treatment by Countries
- 7.1.1 Europe Sickle Cell Disease Treatment Sales by Countries
- 7.1.2 Europe Sickle Cell Disease Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Sickle Cell Disease Treatment by Product
- 7.3 Europe Sickle Cell Disease Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Sickle Cell Disease Treatment by Countries
- 8.1.1 Asia Pacific Sickle Cell Disease Treatment Sales by Countries
- 8.1.2 Asia Pacific Sickle Cell Disease Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Sickle Cell Disease Treatment by Product
- 8.3 Asia Pacific Sickle Cell Disease Treatment by End User
9 Central & South America
- 9.1 Central & South America Sickle Cell Disease Treatment by Countries
- 9.1.1 Central & South America Sickle Cell Disease Treatment Sales by Countries
- 9.1.2 Central & South America Sickle Cell Disease Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Sickle Cell Disease Treatment by Product
- 9.3 Central & South America Sickle Cell Disease Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Sickle Cell Disease Treatment by Countries
- 10.1.1 Middle East and Africa Sickle Cell Disease Treatment Sales by Countries
- 10.1.2 Middle East and Africa Sickle Cell Disease Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Sickle Cell Disease Treatment by Product
- 10.3 Middle East and Africa Sickle Cell Disease Treatment by End User
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Sickle Cell Disease Treatment Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 Eli Lilly
- 11.2.1 Eli Lilly Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly Sickle Cell Disease Treatment Products Offered
- 11.2.5 Eli Lilly Recent Development
- 11.3 Novartis
- 11.3.1 Novartis Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis Sickle Cell Disease Treatment Products Offered
- 11.3.5 Novartis Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Sickle Cell Disease Treatment Products Offered
- 11.4.5 Pfizer Recent Development
- 11.5 Baxter
- 11.5.1 Baxter Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Baxter Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Baxter Sickle Cell Disease Treatment Products Offered
- 11.5.5 Baxter Recent Development
- 11.6 Emmaus Life Sciences
- 11.6.1 Emmaus Life Sciences Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Emmaus Life Sciences Sickle Cell Disease Treatment Products Offered
- 11.6.5 Emmaus Life Sciences Recent Development
- 11.7 Bluebird bio
- 11.7.1 Bluebird bio Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bluebird bio Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bluebird bio Sickle Cell Disease Treatment Products Offered
- 11.7.5 Bluebird bio Recent Development
- 11.8 Blood Therapeutics
- 11.8.1 Blood Therapeutics Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Blood Therapeutics Sickle Cell Disease Treatment Products Offered
- 11.8.5 Blood Therapeutics Recent Development
- 11.9 Sangamo Therapeutics
- 11.9.1 Sangamo Therapeutics Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sangamo Therapeutics Sickle Cell Disease Treatment Products Offered
- 11.9.5 Sangamo Therapeutics Recent Development
- 11.10 Acceleron Pharma
- 11.10.1 Acceleron Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Acceleron Pharma Sickle Cell Disease Treatment Products Offered
- 11.10.5 Acceleron Pharma Recent Development
- 11.11 Arena Pharmaceuticals
- 11.12 Alnylam Pharmaceuticals
12 Future Forecast
- 12.1 Sickle Cell Disease Treatment Market Forecast by Regions
- 12.1.1 Global Sickle Cell Disease Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Sickle Cell Disease Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Sickle Cell Disease Treatment Market Forecast by Product
- 12.2.1 Global Sickle Cell Disease Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Sickle Cell Disease Treatment Revenue Forecast by Product 2019-2025
- 12.3 Sickle Cell Disease Treatment Market Forecast by End User
- 12.4 North America Sickle Cell Disease Treatment Forecast
- 12.5 Europe Sickle Cell Disease Treatment Forecast
- 12.6 Asia Pacific Sickle Cell Disease Treatment Forecast
- 12.7 Central & South America Sickle Cell Disease Treatment Forecast
- 12.8 Middle East and Africa Sickle Cell Disease Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Sickle Cell Disease Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Sickle Cell Disease Treatment. Industry analysis & Market Report on Sickle Cell Disease Treatment is a syndicated market report, published as Global Sickle Cell Disease Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sickle Cell Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
